Here you can find a continually updated listing of Memorial Sloan-Kettering’s current clinical trials for thyroid cancer. To learn more about a study, choose from the list below.
Title |
Investigator |
|---|---|
|
A Phase II Study Evaluating the Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer [Protocol 09-148] |
Sherman, Eric, MD |
|
A Phase II Study of Concurrent Intensity-Modulated Radiation Therapy (IMRT),
Paclitaxel, and Pazopanib/Placebo for the Treatment of Anaplastic Thyroid Cancer [Protocol 10-186] |
Sherman, Eric, MD |
|
A Phase II Study of RO5185426 in Patients with Metastatic or Unresectable Papillary Thyroid Cancer Resistant to Radioactive Iodine [Protocol 11-115] |
Sherman, Eric, MD |
|
Reacquisition of RAI Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment with AZD6244: A Pilot Study [Protocol 09-048] |
Ho, Alan, MD, PhD |
Related Topics
Recommended Links
